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The joint modeling of longitudinal and time-to-event data is an important tool of growing popularity to gain
insights into the association between a biomarker and an event process. We develop a general framework of
flexible additive joint models that allows the specification of a variety of effects, such as smooth nonlinear,
time-varying and random effects, in the longitudinal and survival parts of the models. Our extensions are
motivated by the investigation of the relationship between fluctuating disease-specific markers, in this case
autoantibodies, and the progression to the autoimmune disease type 1 diabetes. By making use of Bayesian
P-splines we are in particular able to capture highly nonlinear subject-specific marker trajectories as well
as a time-varying association between the marker and the event process allowing new insights into disease
progression. The model is estimated within a Bayesian framework and implemented in the R-package
bamlss.
Key words: Anisotropic smoothing; Biomarkers; Longitudinal data; Time-to-event data;
P-Splines;
1 Introduction
The joint modeling of longitudinal biomarkers and the time to disease onset or death offers unique insights
into disease progression in various medical domains (Taylor et al., 2013; Gras et al., 2013; Daher Abdi
et al., 2013). Depending on the disease and the respective biomarker different challenges have to be faced
in joint modeling. In the following, a general framework for the flexible joint modeling of longitudinal
data and time-to-event is presented, which was motivated by unique cohort data from studies exploring the
development of type 1 diabetes (T1D). The research on T1D underwent a paradigm shift in the past decade,
when disease-specific autoantibodies where shown to be diagnostic for the disease before the onset of clin-
ical symptoms and thus paving the way for a pre-clinical diagnosis of T1D (Ziegler et al., 2013; Bonifacio,
2015; Insel et al., 2015). Prior to the onset of clinical symptoms, i.e. the need of insulin substitution, the
disease is already progressing and insulin-producing beta-cells in the pancreas are gradually destroyed by
the body’s own immune system. This immune process, leading to an onset of clinical symptoms within
months up to a decade, can be diagnosed by the emergence of T1D-specific autoantibodies. However, it
remains an open question whether the longitudinal patterns of these autoantibodies might be associated
with the rate of progression to T1D.
In recent years joint models gained larger popularity in the modeling of associations between time-
varying biomarkers and time-to-event. By estimating a submodel for a longitudinal biomarker, usually
∗Corresponding author: e-mail: meike.koehler@helmholtz-muenchen.de, Phone: +49-(0)89-3068-2917, Fax: +49-(0)89-
3187-3144
ar
X
iv
:1
61
1.
01
48
5v
2 
 [s
tat
.M
E]
  2
0 J
an
 20
17
2 Meike Ko¨hler et al.: Flexible additive joint models
a mixed model, jointly with the survival submodel of a time-to-event process, one can account for the
informative censoring and the within-subject errors in the longitudinal model and can incorporate the lon-
gitudinal information, observed only at person-specific discrete timepoints, as a continuous-time covariate
in the survival model. Comprehensive overviews on the topic are given in Tsiatis and Davidian (2004),
Rizopoulos (2012) and Gould et al. (2015). In our work we focus on extensions of so-called shared pa-
rameter models. These assume that a set of parameters influences both the longitudinal and the survival
model, and that there is conditional independence given those parameters.
In T1D research little is known concerning typical trajectories of autoantibodies as biomarkers. At the
same time the observed trajectories show highly nonlinear patterns over time and differ strongly between
subjects, see Figure 1a. In consequence, a flexible specification of individual trajectories in the longitudinal
model is needed in our application.
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Figure 1 Longitudinal marker values of log(IAA+ 1) for five randomly selected subjects in the BABY-
DIAB/BABYDIET study. (a) Observed values (points) and linear interpolation (lines); (b) Observed values
(points) and estimated trajectories (lines).
Much work on joint models has focused on simple parametric longitudinal trajectories, while only
few approaches allow for more flexible, potentially non-parametric longitudinal models. Ding and Wang
(2008) model mean trajectories by B-splines and allow for one multiplicative random effect per subject.
For our application however it remains questionable if such a model is flexible enough to capture the
highly different trajectories. Spline based approaches, that allow also the random effects to be non-linear
functions in time, are mentioned by Song and Wang (2008) and were employed by Rizopoulos and Ghosh
(2011) and Rizopoulos et al. (2014) as well as Brown et al. (2005) and Brown (2009). While allowing
for flexibility, a disadvantage of all these approaches is finding an optimal number of knots to specify
the flexible longitudinal model, e.g. by AIC or DIC. As the number of random effects increases with
the number of knots, this number is limited in practice. We aim to avoid the explicit choice of knots
and number of basis functions by using a penalized spline approach, where a larger number of knots is
specified and smoothness penalties are employed (Lang and Brezger, 2004). Tang and Tang (2015) also
make use of P-Splines in modeling longitudinal trajectories, but do so only in estimating the mean function,
whereas we model also the individual trajectories as smooth functions of time. This is similar in spirit to
3the specification of individual trajectories in Jiang et al. (2015), however we do not assume an underlying
class membership for the random effects.
The estimation of joint models with complex subject-specific trajectories poses a challenge to frequentist
estimation approaches due to the necessary integration over potentially high-dimensional random effects
distributions. Due to this drawback and further advantages of the Bayesian approach in joint modeling,
such as straightforward model assessment and the potential integration of previous knowledge via pri-
ors (Gould et al., 2015), many complex joint models, like e.g. the aforementioned models, are specified
within a Bayesian framework. The most widely used sampling approach for the parameter distributions in
Bayesian joint models is Gibbs Sampling, e.g. Faucett and Thomas (1996); Guo and Carlin (2004); Brown
and Ibrahim (2003), also in conjunction with Metropolis-Hastings algorithms (Tang and Tang, 2015). In
addition, the well established R-package JMbayes (Rizopoulos, 2016a,b) implementing Rizopoulos et al.
(2014) employs a random walk Metropolis-Hastings algorithm. Our Bayesian estimation approach is dif-
ferent as we employ a derivative-based Metropolis-Hastings algorithm, where we draw samples from ap-
proximations of the full conditionals using score vectors and Hessians of the parameters. Despite being
computationally demanding this algorithm shows a high stability in the model estimation, as we also show
in our simulations.
In addition to the need for a flexible longitudinal model, a further generalization of existing joint models
seems necessary in our application, namely a time-varying association between the biomarker and the time-
to-event. Here, the biomarker indicates an ongoing immune process eventually leading to the destruction
of the insulin-producing beta cells. As the activity of the immune system is constantly regulated, it is
plausible that the association between a biomarker and the hazard of T1D varies over time. For example
a recent paper by Meyer et al. (2016) indicated that patients with an autoimmune disease can also present
unique disease-ameliorating autoantibodies. Such a time-varying association has rarely been studied in the
context of joint models. Using a discretized time-scale and a probit model for the discrete hazard function,
Barrett et al. (2015) allow for the association to vary over the discrete time points in their model. However
this flexible specification is not considered in their simulations, the applied examples or the code provided
to fit the models. A time-varying coefficient to associate the marker and the event process is the focus
of the conditional score estimation approach in Song and Wang (2008). This approach can be seen as a
weighted local partial likelihood without any assumptions on the distribution of the random effects. While
this approach accounts for measurement error and short-term biological fluctuations in the longitudinal
marker when modeling the hazard, it only permits inference on the survival parameters and not on the
longitudinal model.
In order to allow for these two extensions, the flexible longitudinal trajectories and a potentially non-
linear time-varying association, both modeled by penalized splines, we develop and implement a highly
flexible framework for joint models available within the R-package bamlss. As we represent all parts of
this flexible joint model as structured additive predictors, which can include linear, parametric but also non-
parametric penalized terms, we are able to allow potentially nonlinear, smooth, random, and time-varying
effects in both submodels. In consequence the possibilities of this implementation go way beyond the two
extensions that originally triggered the development. By applying this flexible model to the combined data
set from two German high-risk T1D birth cohorts we aim to shed further light on the complex relationship
between T1D-associated autoantibodies and the onset of clinical disease.
The remainder of this paper is structured as follows: The general model structure and potential exten-
sions are outlined in Section 2. In Section 3, details on the Bayesian estimation procedure are given. A
thorough testing of the model estimation through simulations is presented in Section 4 and the application
to our T1D research question in Section 5. Concluding remarks are given in Section 6 and technical details
as well as additional figures can be found in the Appendix. The presented model is implemented in the
R-package bamlss (Umlauf et al., 2016). Source code to reproduce the simulation results is available in
the ancillary material.
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2 Methods
In the following, the general setup for additive joint models is presented with a special focus on two
extensions in the present work compared to existing approaches: the flexible specification of longitudinal
trajectories as well as the time-varying association between longitudinal marker and event. An overview
of potential further model specifications illustrates the flexibility of the presented model family.
2.1 General Setup
For every subject i = 1, . . . , n we observe a potentially right-censored follow-up time Ti and the event
indicator δi (1 if subject i experiences the event, 0 if it is censored). We model the hazard of an event at
time t as
hi(t) = exp {ηi(t)} = exp {ηλi(t) + ηγi + ηαi(t) · ηµi(t)} (1)
including in the full predictor η a predictor ηλ for all survival covariates that are time-varying or have
a time-varying coefficient including the log baseline hazard, a predictor for baseline survival covariates
ηγ as well as a predictor ηα representing the potentially time-varying association between the longitudinal
marker ηµ and the hazard.
We also observe a longitudinal response yi = [yi1, · · · , yini ]> at the potentially subject-specific ordered
time points ti = [ti1, · · · , tini ]> with ti1 ≤ · · · ≤ tini ≤ Ti. t = [t>1 , · · · , t>n ]> denotes the vector of the
N =
∑n
i=1 ni longitudinal measurement time points of all subjects. The longitudinal response at tij with
j = 1, . . . , ni is modeled as
yij = ηµi(tij) + εij (2)
with independent errors εij ∼ N(0, exp[ησi(tij)]2) allowing to also model the error variance. Thus
ηµi(tij) represents the longitudinally observed marker value without error at timepoint tij . This “true”
marker value serves as a continuous-time covariate in the hazard in (1) and links the two model equations.
Each predictor ηki with k ∈ {λ, γ, α, µ, σ} is a structured additive predictor, i.e. a sum ofMk functions
of covariates xi,
ηki =
Mk∑
m=1
fkm(xki).
Different subsets xki of xi can serve as covariates for the different predictors, with each fkm typically
depending on one or two covariates. For time-varying predictors the functions can also dependent on
time ηki(t) =
∑Mk
m=1 fkm(xki(t), t) with a potentially time-varying covariate vector xki. We express the
vector of predictors for all subjects as ηk = [ηk1, · · · , ηkn]>. These vectors are of length n for the survival
part of the model (1), where ηk(t) for k ∈ {λ, α, µ} denotes that predictors are evaluated at time t. In the
longitudinal part of the model (2) the vector ηk(t) for k ∈ {µ, σ} is of lengthN , containing entries ηki(tij)
for all j = 1, . . . , ni, i = 1, . . . , n , i.e. evaluations at all observed time points t for the corresponding
subjects.
The functions fkm(xki) can model a variety of effects, such as smooth, spatial, time-varying or random
effects terms which can be expressed in a straightforward notation for every termm of predictor k by using
suitable basis function expansions and corresponding penalties Pkm. In a generic setup we let
fkm = Xkmβkm and Pkm =
1
τ2km
β>kmKkmβkm, (3)
5with the vector of function evaluations fkm stacked for each subject, the design matrix Xkm, the coef-
ficient vector βkm, the penalty matrix Kkm and the variance parameter τ2km that controls the amount of
penalization of the respective term. In the Bayesian setting a penalization is imposed by specifying an
appropriate prior distribution for the parameters, βkm ∼ N(0, [ 1τ2kmKkm]
−) with A− denoting the gen-
eralized inverse of A, as presented in more detail in section 3.3. Note that these basic penalties can be
extended further as shown in more detail in the next subsection.
In analogy to the differences in form in the generic vector of predictors, i.e. ηk, ηk(t) and ηk(t), the
form of the generic vectors of function evaluations fkm and the generic design matrices Xkm also differs
between predictors and submodels. For ease of notation we drop the subscriptm for the different terms per
predictor in this illustration. For the time-constant survival predictor ηγ , we observe a vector of covariates
xγi for every subject and stack these in the design matrix Xγ = [xγ1, · · · ,xγn]> of size n× pγ resulting
in the vector of function evaluations fγ = [fγ(xγ1), · · · , fγ(xγn)]>. For the time-varying predictors of
the survival part, i.e. k ∈ {λ, α, µ}, xki(t) denotes the subject covariate vector, including basis evaluations
for non-linear effects over time at time t, resulting in the design matrix Xk(t) of evaluations of size n× pk
and the vector fk(t) = [fk(xk1(t), t), · · · , fk(xkn(t), t)]> of length n for each t. Finally for predictors
in the longitudinal submodel, i.e. k ∈ {µ, σ}, we observe the ni × pk covariate matrix xki(ti) for every
subject i at the ni subject-specific time points, resulting in the N × pk stacked design matrix Xk(t) for all
subjects at all timepoints with the vector fk(t) = [fk(xk1(t1), t1)>, · · · , fk(xkn(tn), t1)>]>.
To illustrate how different effects are subsumed under this notation by the specification of the respective
design matrices, we formulate a standard shared parameter joint model within this framework. Note that
we drop the index m for predictors which consist of only one term. We specify the log-baseline hazard
ηλ(t) = fλ(t) = Xλ(t)βλ as a smooth function in time by P-splines with a B-spline basis, fλ(t) =∑D
d=1 βdBd(t) =: x
>
λ (t)βλ, and the penalty matrix Kλ = D
>
r Dr with Dr as the r-th difference matrix
of appropriate dimension (Eilers and Marx, 1996). In the Bayesian setting, using Bayesian P-Splines,
smoothing is induced by appropriate prior specification, where the difference penalties are replaced by
their stochastic analogues, i.e. random walks (Lang and Brezger, 2004). Here xλ(t) contains the evaluation
of the D B-spline basis functions Bd(t) at time t. As the baseline hazard is not subject-specific, Xλ(t)
contains n stacked replications of xλ(t). Parametric effects of baseline survival covariates are modeled
as ηγ = fγ = Xγβγ , where each row of Xγ contains the subject-specific covariate vector and Kγ is
taken as the zero-matrix 0. The usual time-constant association between longitudinal and survival model
is implemented as ηα = fα = 1nβα, where 1n is a vector of ones of length n and Kα = 0. The
predictor vector for the longitudinal part with a random intercept in the linear mixed effects model can
be specified as ηµ(t) = fµ1(t) + fµ2(t) = Xµ1(t)βµ1 + Xµ2(t)βµ2, where Xµ1(t)βµ1 are the design
matrix and coefficient vector of the fixed effects potentially including a parametric effect of time with
Kµ1 = 0, and Xµ2(t)βµ2 is a basis matrix representation of a random intercept. In more detail Xµ2 is
an N × n indicator matrix, where the ith column indicates which longitudinal measurements belong to
subject i, βµ2 = [βµ21, · · · , βµ2n] denotes the coefficient vector and an n × n identity matrix as penalty
Kµ2 = In ensures βµ2i ∼ N(0, τ2µ2) independently. Finally the error variance is modeled as constant
using ησ(t) = fσ(t) = 1Nβσ with Kσ = 0.
2.2 Important extensions of current models
A special focus in our joint model approach lies on the flexibility of the longitudinal predictor ηµ. We
model the trajectory for every subject as the sum of fixed covariate effects, a smooth function of time, a
random intercept as well as smooth subject-specific deviations from this function over time,
ηµi(t) = fµ1 (t) + fµ2 (i) + fµ3 (t, i) +
Mµ∑
m=4
fµm (xµm) . (4)
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In this parameterization fµ1(t) is a smooth effect of time, constructed like fλ(t), and fµ2(i) is a random
intercept as illustrated in the previous sub-section. The term fµ3(t, i) denotes the smooth subject-specific
deviations from the global time effect using functional random intercepts (Scheipl et al., 2015). Addition-
ally linear or parametric effects, including a global intercept, as well as further smooth effects of covariates
can be represented by an extra term in
∑Mµ
m=4 fµm(xµm). The basis for the functional random intercepts
can be specified within the basis function approach as row tensor products of the marginal basis of a ran-
dom intercept, marked by the subscript s, and the marginal basis for a smooth effect of time, marked by
the subscript t. We denote the vector of function evaluations at every observed longitudinal time point in t
for the corresponding subjects in i = [1, · · · , n]> as
fµ3 (t, i) = (Xµ3s Xµ3t)βµ3 = Xµ3βµ3, (5)
where Xµ3s is an N × n indicator matrix as the basis for a random intercept as specified for Xµ2 in the
previous sub-section, Xµ3t is anN×D matrix of evaluations of a marginal spline basis at t and Xµ3 is the
N × nD basis matrix resulting from the row tensor product. The row tensor product  of a p × a matrix
A and a p× b matrix B is defined as the p× ab matrix AB = (A⊗ 1>b ) · (1>a ⊗B) with · denoting
element-wise multiplication.
The corresponding penalty term is constructed from the marginal penalty matrices:
Pµ3 = β
>
µ3
(
1
τ2µ3s
Kµ3s ⊗ It + 1
τ2µ3t
Is ⊗Kµ3t
)
βµ3 = β
>
µ3
(
1
τ2µ3s
K˜µ3s +
1
τ2µ3t
K˜µ3t
)
βµ3, (6)
where ⊗ denotes the Kronecker product, Kµ3s = In is the penalty matrix for the random effect and Kµ3t
is an appropriate penalty matrix for the smooth effect of time such as a difference penalty for B-splines.
The enlarged penalty matrices K˜µ3s and K˜µ3t yield a penalization for every subject, resulting in a random
effects structure and a smoothness penalization across time for each subject. Note that by specifying two
variance parameters, τ2µ3s and τ
2
µ3t, the amount of penalization can differ in the direction of time and
across subjects, resulting in an anisotropic penalty. This specification allows for a highly flexible modeling
of individual trajectories over time.
Given the specification of a separate global intercept and subject-specific random intercepts, the con-
straints
∫
fµ1(t)dt = 0 and
∫
fµ3(t, i)dt = 0 for every i are set in order to ensure identifiability. The
necessary linear constraint
∫
fµ1(t)dt = 0 is implemented for B-splines by transforming the marginal ba-
sis Xµ3t into anN×(D−1) matrix X˙µ3t for which it holds that X˙µ3t1D−1 = 0 as shown in Wood (2006,
chapter 1.8), and adjusting the penalty accordingly. Transforming the marginal basis and constructing the
row tensor product Xµ3 using the transformed basis matrix X˙µ3t with correspondingly adjusted marginal
penalty ensures that the identification constraint
∫
fµ3(t, i)dt = 0 for every i is also fulfilled.
As a second extension to existing shared-parameter models we also specify the association between
longitudinal and survival model as a structured additive predictor ηα. In consequence, this predictor can
be modeled as a function of time and/or other covariates. Motivated by our applied research questions
we model ηα(t) = fα(t) as a smooth function of time by using penalized splines, as specified for the
baseline hazard. This allows us to find patterns beyond the standard joint model specification to explain
the relationship between longitudinal marker and survival process. These patterns could for example be
critical time windows in which a non-zero effect of ηα is present or a potential change in the direction of
the association ηα over time.
2.3 Further potential specifications
The presented general framework of structured additive joint models allows for a variety of different effect
specifications by making use of the flexibility of Bayesian structured additive regression models (Fahrmeir
7et al., 2004) as well as adding functional extensions (Scheipl et al., 2015). Besides the presented smooth,
time-varying, random effects and functional random intercept terms, a variety of further effects can be
incorporated. Table 1 gives an overview of possible terms. All these terms can be specified by formulating
the desired effect in a basis function representation with an appropriate penalty term.
Table 1 Effects fkm(xki) that can be specified within a predictor ηk in structured additive joint models;
modified from a similar table in Scheipl et al. (2015).
covariate (subset of x) fkm(xk) constant over t fkm(xk) varying over t
no covariate scalar intercept 1 · β smooth effect of time f(t)
scalar covariate z linear effect z · β linear effect varying over time z · f(t)
smooth effect f(z) smooth effect over time f(z, t)
spatial covariate(s) s spatial effect f(s) spatial effect over time f(s, t)
grouping variable g random intercept βg functional random intercept fg(t)
scalar and grouping variable random slope z · βg functional random slope z · fg(t)
vector of scalars [z1, z2] linear interaction z1 · z2 · β linear interaction over time z1 · z2 · f(t)
varying coefficient z1 · f(z2)
smooth effect f(z1, z2)
For details on the specification of such effects please refer to Fahrmeir et al. (2004); Scheipl et al.
(2015); Wood (2006). Further details on the practical aspects within our implementation are given in
section 3.4.
3 Estimation
We estimate the model in a Bayesian framework using Newton-Raphson and Markov chain Monte Carlo
(MCMC) algorithms.
3.1 Likelihood
Under the assumption of conditional independence of the survival outcomes [Ti, δi] and the longitudinal
outcome yi, given the random effects, the likelihood of the specified joint model is the product of the two
submodel likelihoods Lsurv and Llong for the survival and the longitudinal model
L [θ|T, δ,y] = Lsurv [ηλ(T),ηγ ,ηα(T),ηµ(T)] · Llong [ηµ(t),ησ(t)] ,
where θ is the vector of all parameters in the model and T = [T1, · · ·Tn]>, δ = [δ1, · · · δn]>, and
y = [y>1 , · · ·y>n ]> are the response vectors. The additive predictors implicitely also depend on covariates
and model parameters. The log-likelihood of the survival part is
`surv [ηλ(T),ηγ ,ηα (T) ,ηµ (T)] = δ
>η(T)− 1>nΛ (T) , (7)
where Λ(T) = [Λ1(T1), . . . ,Λn(Tn)]> is the vector of the cumulative hazard rates
Λi(Ti) = exp(ηγi)
∫ Ti
0
exp[ηλi(u) + ηαi(u) · ηµi(u)]du and η(T) = [η1(T1), · · · , ηn(Tn)] denotes the
vector of the full predictors evaluated at the subject-specific survival times. The log-likelihood of the
longitudinal part of the model is
`long [ηµ (t) ,ησ (t)] = −N
2
log(2pi)− 1>Nησ (t)−
1
2
(y − ηµ (t))>R−1(y − ηµ (t)). (8)
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ηµ(t) and ησ(t) are the predictor vectors of length N corresponding to the longitudinal response y and
R = blockdiag(R1, · · · ,Rn), whereRi can reflect the error structure of interest. In our case, we assume
Ri = diag(exp[ησi(ti1)]
2, · · · , exp[ησi(tini)]2) so thatR reduces to a diagonal matrix.
3.2 Priors and Posterior
In this general framework above, a variety of terms (cf. Table 1) can be specified using corresponding pri-
ors. For linear or parametric terms we use vague normal priors on the vectors of the regression coefficients,
e.g. βkm ∼ N(0, 10002), approximately corresponding to the precision matrices Kkm = 0 as explained
above. Smooth and random effect terms are regularized by placing suitable multivariate normal priors on
the coefficients
p(βkm|τ2km) ∝
(
1
τ2km
) rank(Kkm)
2
exp
(
1
2τ2km
β>kmKkmβkm
)
with precision matrix Kkm as specified in the penalty (3). We use independent inverse Gamma hyperpriors
τ2km ∼ IG(0.001, 0.001) to obtain an inverse Gamma full conditional for the variance parameters. In
addition to the inverse gamma distribution, different priors are possible for the variance parameters in
our implementation, such aus Half-Cauchy and Half-normal distributions. The variance parameters τ2km
control the trade-off between flexibility and smoothness in the nonlinear modeling of effects. As such they
can be interpreted analogous to inverse smoothing parameters in a frequentist approach.
For anisotropic smooths, when multiple variance parameters τ 2km = (τ
2
kms, τ
2
kmt) are involved as in (6),
we use the prior
p(βkm|τ 2km) ∝
∣∣∣∣ 1τ2kms K˜kms + 1τ2kmt K˜kmt
∣∣∣∣ 12 exp(−12β>km
[
1
τ2kms
K˜kms +
1
τ2kmt
K˜kmt
]
βkm
)
.
(9)
The resulting posterior of the model is
p(θ|T, t, δ,y) ∝ Lsurv [ηλ(T),ηγ ,ηα(T),ηµ(T)] · Llong [ηµ(t),ησ(t)]
·
∏
k∈{λ,γ,α,µ,σ}
Mk∏
m=1
[
p(βkm|τ 2km)p(τ 2km)
]
,
where p(βkm|τ 2km) are the priors of the vectors of regression parameters and p(τ 2km) are the priors of
the variance parameters for each term m and predictor k.
3.3 Bayesian Estimation
Point estimates of θ can be obtained by posterior mode and posterior mean estimation. We estimate the
posterior mode by maximizing the log-posterior of the model using a Newton-Raphson procedure, the
posterior mean is obtained via derivative-based Metropolis-Hastings sampling and thus computationally
demanding. We therefore recommend to use posterior mode estimates for a first quick assessment of the
model and in order to obtain starting values for the posterior mean sampling.
In the maximization of the log-posterior to obtain the posterior mode, we update blockwise each term
m of predictor k in each iteration l as
β
[l+1]
km = β
[l]
km − ν[l]kmH
(
β
[l]
km
)−1
s
(
β
[l]
km
)
9with potentially varying steplength ν[l]km and with the score vector s(βkm) and the HessianH(βkm), which
can be found in Appendix A. We optimize the variance parameters in each updating step to minimize the
corrected AIC (AICc, Hurvich et al., 1998), which showed good performance in smoothing parameter
estimation in Belitz and Lang (2008). Additionally we optimize the steplength ν[l]km over (0, 1] in each
step to maximize the log-posterior. We assume the coefficients to have an approximately normal posterior
distribution and derive credibility intervals fromN(βˆkm, [−H(βˆkm)]−1) for quick approximate inference.
For the posterior mean sampling we construct approximate full conditionals pi(βkm|·) based on a second
order Taylor expansion of the log-posterior centered at the last state β[l]km, similar to Fahrmeir et al. (2004),
Klein et al. (2015a) and Klein et al. (2015b). The proposal density from this approximate full conditional
is proportional to a multivariate normal distribution with the precision matrix (Σ[l]km)
−1 = −H(β[l]km) and
the mean µ[l]km = β
[l]
km−H(β[l]km)−1s(β[l]km). In each iteration l of the sampler and for updating block km
a candidate β∗km is drawn from the proposal density
q(β∗km|β[l]km) = N(µ[l]km,Σ[l]km)
and is accepted with the probability
a(β∗km|β[l]km) = min
(
pi(β∗km|·)q(β[l]km|β∗km)
pi(β
[l]
km|·)q(β∗km|β[l]km)
, 1
)
,
where pi(β∗km|·) is the full conditional for the candidate and pi(β[l]km|·) is the full conditional for the current
iterate. By drawing candidates from a close approximation of the full conditional, using the log-posterior
centered at the previous state, we approximate a Gibbs sampler and achieve high acceptance rates and good
mixing.
For the sampling of the variance parameters τ2km Gibbs sampling is employed, as the full conditionals
pi(τ2km|·) follow an inverse Gamma distribution, if inverse Gamma hyperpriors are used. Slice sampling is
employed when no simple closed-form full conditional can be obtained as for example in the sampling of
variance parameters for anisotropic smooths (9) or for other hyperpriors.
3.4 Implementation details
The model estimation is implemented within R (R Core Team, 2016) in the package bamlss (Umlauf
et al., 2016) that allows the Bayesian estimation of a variety of models within the framework of Bayesian
Additive Models for Location, Scale and Shape. The specification of appropriate design matrices and
penalties for the desired effects is conducted internally via the R-package mgcv (Wood, 2011). In con-
sequence the full range of implemented smoothing approaches, such as P-splines, thin-splate regression
splines, random effects, and Markov Random Fields, can be used within our implementation. We refer
to Wood (2006) and Wood et al. (2016) for further information on model terms, bases and penalities. In
our model specification in the simulations and the application we make use of Bayesian P-splines (Lang
and Brezger, 2004) to model smooth effects. As the integrals in the survival likelihood as well as in the
respective scores and Hessians have no analytical solution, they are approximated numerically using the
trapezoidal rule and a fixed number of 25 integration points. Starting values for the posterior mean sam-
pling are obtained by estimating the posterior mode of the joint model. The posterior mean sampling is
implememented to potentially run in parallel on a number of specified cores on Linux systems. More
details can be found in the documentation of the bamlss R-package.
4 Simulation
We assess the estimation of our model by means of a simulation study with focus on two aspects: First,
comparing our results with the established joint model implementation in JMbayes (Rizopoulos, 2016a)
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for models with time-constant ηα. Second, we want to assess the ability to model highly complex longi-
tudinal trajectories as well as a time-varying effect of ηα(t), the two important new extensions within our
framework. With this simulation we also aim to gain insights into the estimation quality of the model when
applied to real data sets of T1D cohorts that motivated our methods development. Therefore we simulate
two differing data situations, mimicking real cohort data. The first simulated data setting, corresponding
to the cohort data presented in the Application Section, has less subjects, at more variably spaced time
points but with a longer follow up, than the other. Finally we aim to assess how well the posterior mode
estimation can approximate the effects in comparison with the posterior mean estimates.
4.1 Simulation design
For every setting we generate longitudinal measurements for n subjects at a fixed grid of time points
P based on a true longitudinal model ηµ(t) as specified in (4) with the time effect fµ1 (t) = 0.1(t +
2) exp(−0.075t), the random intercepts fµ2 (i) = ri where ri ∼ N(0, 0.25), the functional random inter-
cepts fµ3 (t, i) = Xµ3βµ3, and the global intercept and covariate effect fµ4(xµi) = 0.5 and fµ5(xµi) =
0.6 sin(x2i) with x2i ∼ unif(−3, 3). We simulate the functional random intercepts flexibly by P-Splines
where we draw the true vector of spline-coefficients for all subjects from βµ3 ∼ N(0, [(1/τ2s )K˜s +
(1/τ2t )K˜t]
−1) as in (6) with Kt = D>2 D2, τ
2
s = 1 and τ
2
t = 0.2. The hazard hi(t) for every subject
is calculated according to (1) using the true survival predictor functions ηλ(t) = 1.4 log((t + 10)/1000),
ηγi = 0.5 sin(x1i), with x1i ∼ unif(−3, 3) and ηα(t) varying for the two simulation settings. Based on
hi(t), survival times are generated for every subject as described in Bender et al. (2005) and Crowther and
Lambert (2013). Every subject is censored after max(P) and we additionally apply uniform censoring
U(0, 1.5 ·max(P)) to the survival times. In order to mimic missing measurements in the real data, p% of
the remaining longitudinal data are randomly set to missing after censoring in line with the survival times.
Longitudinal obervations are obtained from ηµi(t) by adding independent errors ij ∼ N(0, 0.32) for each
tij in t.
The influence of different data structures on the estimation is assessed by simulating two different data
settings in each of the two simulations settings. In the smaller data setting, a, observations for na =
150 subjects are generated at the measurements points Pa = [0, 1, . . . , 120] where pa = 75% of the
longitudinal measurements are missing and on average 108 (72 %) events occur, compared to nb = 300
subjects at the time points Pb = [0, 3, . . . , 72] with pb = 10% missings and 165 (55 %) events in the larger
data setting, b.
In each data and simulation setting we draw Q = 200 samples. To ensure convergence, we run the
model estimation with 23000 samples, a burn-in of 3000 and a thinning of 20, yielding 1000 samples, as
assessed in preliminary simulations. For each estimated model q within a simulation setting we assess
bias, mean-squared error (MSE) and frequentist coverage of the 95% credibility intervals, defined by the
2.5th and the 97.5th percentiles of the MCMC samples for the posterior mean and the approximate normal
intervals for the posterior mode. We evaluate bias, MSE and coverage both averaged over all time points
and averaged per time point. For the predictors in the longitudinal model, i.e. k ∈ {µ, σ}, the average bias
in each sample q isBqk =
1
N
∑n
i=1
∑ni
j=1[ηˆ
q
ki(tij)−ηqki(tij)] where ηˆki denotes the estimate. To assess the
model fit over time we also evaluate the bias per timepoint Bqk(t) =
1
n
∑n
i=1[ηˆ
q
ki(t)− ηqki(t)] for all t in P .
The computations for MSE and coverage are analoguous. For the survival predictors, i.e. k ∈ {γ, λ, α},
the average bias is Bqk =
1
n
∑n
i=1[ηˆ
q
ki(Ti) − ηqki(Ti)] using evaluations at the subject’s event times. The
bias of the time-varying survival predictor ηλ, and for setting 2 also ηα, is additionally evaluated at the
fixed grid of time points t in P as Bqk(t) = 1n
∑n
i=1[ηˆ
q
ki(t) − ηqki(t)] with MSE and coverage computed
accordingly. These error measures are then averaged over all Q samples per setting.
For the comparison with the joint model implementation in JMbayes in settings 1a and 1b, data is
generated with ηα(t) = 1 as time-constant. In our implementation we model the longitudinal submodel
by P-splines with cubic B-splines, a second order difference penalty and 12 knots (4 internal knots), for
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both the overall mean as well as the individual trajectories. After application of the constraints this yields
7 · n basis functions. For the time-varying effect of the baseline hazard, ηλ, as well as the nonlinear effect
in ηγ we use 10 knots (2 internal knots) resulting in 5 basis functions per effect after application of the
constraints. In order to achieve a comparable model in the package JMbayes we model nonlinear effects
in the longitudinal submodel and survival covariate effects by B-splines and determine the number of
knots to minimize the DIC in preliminary simulations. Details on the inclusion of nonlinear effects in both
submodels can be found in the source code of the ancillary material. As a result we model the longitudinal
part by cubic B-splines for both the fixed and random effects with 1 internal knot for the larger data setting
and without internal knots for the smaller data setting, resulting in 4 and 3 basis functions for both the
fixed and random effects of time, respectively. As prior simulations had shown convergence issues when
the covariance matrix of the random effects was estimated as unrestricted, we restrict it to be diagonal,
resulting in independent random effects. Also based on DIC from preliminary simulations we specify the
effect in ηγ in the survival part with cubic B-splines with 3 internal knots using 5 basis functions. We
model the baseline hazard with P-splines using the default settings from JMbayes, i.e. a cubic B-spline
basis with 17 basis functions and a second order difference penalty. For the MCMC procedure we also use
the default settings of 20000 iterations, including a burn-in of 3000 and a thinning such that 2000 samples
are kept.
In our second simulation, i.e. settings 2a and 2b, we specify the longitudinal trajectories as before
but generate data using a time-varying association predictor ηα(t) = cos((t − 33)/33) for data in a and
ηα(t) = cos((t− 20)/20) for b in order to achieve a similar shape despite a differing time scale. We fit the
model using the same specification as in setting 1. Additionally ηα is modeled as a P-spline with 10 knots
(2 internal knots) resulting in 5 basis functions after application of the constraints.
4.2 Simulation results
The focus of the first simulation is the comparison with the package JMbayes regarding the accuracy of
the modeling of the longitudinal trajectories and the time-constant association parameter ηα in settings 1a
and 1b. Table 2 shows the MSE, bias and coverage for the estimation of ηα.
Table 2 Posterior mean simulation results from bamlss and results from JMbayes
from setting 1 (time-constant ηα) for small (a) and large (b) data sets.
MSE bias coverage
a b a b a b
ηα bamlss 0.032 0.016 0.003 −0.009 0.925 0.970
JMbayes 0.049 0.021 0.100 0.048 0.840 0.890
ηγ + ηλ bamlss 0.127 0.077 −0.007 0.011 0.935 0.946
JMbayes 0.155 0.101 −0.095 −0.048 0.743 0.742
ηµ bamlss 0.022 0.028 0.001 0.000 0.944 0.942
JMbayes 0.031 0.029 −0.001 0.008 ∗ ∗
ησ bamlss 0.001 0.001 0.009 0.014 0.940 0.875
JMbayes 0.007 0.002 0.080 0.039 ∗ ∗
∗ No credibilty intervals and thus no coverage could be calculated for these predictors.
For both methods ηα is estimated more precisely and with a higher coverage in the larger data setting b
compared to a. In both data settings bamlss achieves lower MSE, less bias and a higher coverage in the
estimation of the association compared to JMbayes. For JMbayes the coverage for ηα is not satisfactory
in both settings (0.840 and 0.890). The further survival predictors, ηγ and ηλ, are parameterized differently
in the two estimation methods with regard to the intercept term and sum-to-zero constraints. Therefore
we assess only the prediction quality of ηλ + ηγ . We observe that JMbayes shows a higher bias in the
estimation of the sum of these two predictors.
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Regarding the longitudinal submodel for ηµ both methods are fairly equal regarding the average MSE
over the larger data setting (bamlss: 0.028 vs. JMbayes: 0.029), but our approach seems to be more
precise in the smaller data setting (bamlss: 0.022 vs. JMbayes: 0.031). To further understand the cause
of this difference we look at the bias in the estimation of ηµ over the whole observed time course for the
smaller data setting. As shown in Figure 2, JMbayes seems to underestimate some nonlinearity of the
true predictor. Both methods show higher uncertainty for later time points when, due to censoring and the
occurrence of events, less information is available.
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Figure 2 Comparison of the bias over time for ηµ(t) estimates from bamlss and JMbayes in setting
1a.
Finally, the estimation of the error variance is more precise in bamlss. For the longitudinal predictors
we did not achieve to calculate credibility intervals in JMbayes.
There are large runtime differences where JMbayes models took on average 4 minutes and 7 minutes
for data setting a and b, respectively, and the implementation bamlss, due to the more flexible functional
random effects specification, took on average 6 hours and 39 hours to run on a single core of a 2.60 GHz
Intel Xeon Processor E5-2650. Through parallel computating, e.g. on 10 cores of a Linux system, the run
times would reduce to 1.3 and 8.5 hours, respectively.
The aim of the second simulation setting is to shed light on the precision of the estimation of all pre-
dictors in the model with a special focus on the estimation of ηα, which is nonlinear in time. Additionally,
we also compare the precision of the posterior mode to the posterior mean estimation. Table 3 gives an
overview of the estimation precision of all predictors.
Similarly to setting 1 we observe an effect of sample size: All survival predictors (ηλ, ηγ , ηα) show a
smaller MSE for data setting b compared to a probably due to the higher number of events. In contrast,
the MSE is smaller for the estimation of ηµ in data setting a compared to b potentially due to the longer
follow-up and a slightly higher number of longitudinal observations per subject. Whereas the precision of
the point estimates is overall similar or only slightly worse for the posterior mode compared to the posterior
mean estimation, the coverage is not acceptable for the posterior mode but close to 95% for the posterior
mean. The only exception is the estimation of ησ , where the coverage is somewhat lower for the posterior
mean. As ησ is very precisely estimated and formal inference is usually not of interest for this predictor,
we do not rate this under-coverage as too problematic.
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Table 3 Posterior mode and posterior mean simulation results for setting 2 (time-varying ηα(t)) for small
(a) and large (b) data sets.
MSE bias coverage
a b a b a b
ηα mean 0.172 0.078 0.007 0.002 0.940 0.961
mode 0.177 0.117 0.058 0.069 0.608 0.593
ηγ mean 0.097 0.062 −0.035 −0.032 0.931 0.948
mode 0.089 0.059 0.022 −0.001 0.804 0.795
ηλ mean 0.083 0.065 0.000 0.000 0.945 0.957
mode 0.101 0.082 0.000 0.000 0.592 0.549
ηµ mean 0.022 0.028 0.000 0.000 0.943 0.942
mode 0.025 0.031 0.000 0.000 0.882 0.865
ησ mean 0.000 0.001 0.009 0.015 0.905 0.855
mode 0.004 0.004 −0.057 −0.057 0.175 0.045
In order to illustrate the precision in the time-varying effect estimates and to assess the cause of differ-
ences in MSE, Figure 3 displays the true and estimated predictors ηλ(t) and ηα(t). Overall the estimated
predictors match the true functions quite well. For the smaller data sets there is more uncertainty in the
estimation, especially at later time points, when less subjects are still observed.
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Figure 3 True (black) and estimated (coloured) predictors from posterior mean und posterior mode esti-
mation for small (a) and large (b) data sets in simulation setting 2. Left: ηλ(t); right: ηα(t).
With on average only 15 and 22 minutes to run for data setting a and b respectively, the posterior mode
estimation has clear advantages in computation time over the more precise posterior mean estimation with
7 and 43 hours on average in this setting. Again through parallel computating on 10 cores, the time for the
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posterior mean estimation would reduce to 1.5 and 9.3 hours, respectively.
In conclusion, our simulations show that the estimation of models with constant associations between
marker and event performs well, even outperforming the implementation in JMbayes in some aspects.
The estimation of more flexible models that are newly covered by our approach in contrast to existing im-
plementations, i.e. with a time-varying assocation parameter and the specification of flexible trajectories,
is equally satisfactory. While the more precise posterior mean estimation is time-consuming, the poste-
rior mode offers a computationally efficient way to quickly assess the point estimates in a given model
specification, even though credibility bands are only approximate.
5 Application
In order to gain insights into our motivating research question we apply the model to a combined data
set of two ongoing German T1D risk cohorts to investigate whether longitudinal trajectories of insulin
autoantibodies (IAA) are associated with the rate of progression to T1D. Whereas different autoantibodies
are diagnostic for a preclinical stage of the disease, our focus lies on the analysis of the levels of IAA as
a marker from the time when it first exceeded a specific threshold, called seroconversion, to the onset of
T1D or loss to follow-up. The marker IAA is most often the first autoantibody to appear (Ziegler et al.,
1993, 1999; Hummel et al., 2004a). Both its initial value at seroconversion as well as its mean over time
have been shown to be positively associated with the emergence of T1D and negatively related to the age
at T1D diagnosis (Steck et al., 2011, 2015).
The BABYDIAB and BABYDIET studies, both propective birth cohorts with a joint study protocol,
aim to investigate the natural history of T1D development. In these studies children with familial increased
risk of T1D were followed from birth to the development of T1D or loss to follow-up for up to 21 years
(Ziegler et al., 1993, 1999; Hummel et al., 2004b, 2011). In both studies, autoantibody measurements were
taken at age 9 months and 2, 5, 8, 11, 14 and 17 years and additionally every 6 months after positive islet
autoantibodies had emerged. The exact age at the emergence of clinical T1D was assessed also between
study visits.
In our joint model we use data of n = 127 children who developed IAA during follow-up of which 69
(54%) progressed to T1D. The subject’s progression times are censored at 15 years after seroconversion
due to the extremely low sample size at later time points. In total N = 894 longitudinal measurements
of IAA after seroconversion were used and log-transformed log(IAA + 1) for the analysis. We model
subject’s transformed autoantibody levels using functional random intercepts and two further covariates.
First, the age at seroconversion is included as a linear effect and second a binary variable indicates whether
the autoantibody was among the first autoantibodies to appear. We model the association between marker
and event, ηα(t), to be a non-linear function of time. Further we allow the covariates in the longitudinal
model to also influence the survival process directly and expect a positive association between the age
at seroconversion and the time to T1D (Steck et al., 2011; Ziegler et al., 2013). In our Bayesian model
estimation we sample for 33000 iterations with a burnin of 3000 and thinning of 30 to obtain 1000 sam-
ples, with starting values for the posterior mean estimation obtained from the posterior mode estimates.
Convergence is assessed by the inspection of traceplots, of which a subset is presented in Appendix B. In
order to assess the sensitivity of the results to the number of knots we specify three models with differing
numbers of knots. We specify two models using either 12 (i.e. 4 internal) knots or 20 (i.e. 8 internal) knots
for the overall mean as well as the individual trajectories in the functional random intercepts and 10 (i.e.
2 internal) knots in the survival submodel. Additionally we specify a model with 20 (i.e. 8 internal) knots
for nonlinear terms in both, the longitudinal and the survival submodels.
The results from the three specified models in our sensitivity analysis are highly similar for all predictors
with regard to mean estimates and the credibility intervals. However we observe lower DIC for the models
with more knots in the functional random intercepts along with a closer fit of the individual trajectories
15
and more narrow credibility intervals for the estimated association ηα(t) (cf. Figure A1 in Appendix B).
Using more knots in the survival submodel results in a better mixing in the traceplots but a slightly higher
DIC. Hence we assume the results to be robust regarding the exact number of knots and present results of
the model with the lowest DIC in the following.
As shown in Figure 1b for 5 randomly selected subjects, we are able to closely approximate the indi-
vidual non-linear trajectories of IAA. The association between the marker and the onset of clinical T1D is
estimated as stable over time with an average slope of -0.01 [95% credibility interval: -0.08, 0.06].
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Figure 4 Estimated posterior mean of ηα(t) with 95% pointwise credibility bands (shaded area), observed
event times (rugs bottom) and censoring times (rugs top), and number of subjects at risk per time point
(bottom).
The average slope was defined as the mean over the first derivative of the association ηα(t) evaluated
at all observed event and follow-up times T, and its posterior distribution can be easily obtained by nu-
merically deriving η′α(t) in every sample. The credibility interval for the estimated association is above 0
from 0.5 to 6.5 years after seroconversion and there is more uncertainty when less information is available,
i.e. when less event and follow-up times are observed and when less subjects remain in the risk set, as
indicated by the credibility intervals (Figure 4). In the longitudinal submodel we observe that trajectories
have a lower level, if subjects seroconverted at an older age (in years, βµ4 = −0.07; 95% credibility
interval: [-0.14, -0.01]) and a higher level if IAA was amongst the first markers to appear (βµ5 = 0.90;
[0.24, 1.55]). In the survival submodel the log-hazard is decreased if IAA was amongst the first markers to
appear (βγ2 = −0.94; [-1.69, -0.14]). In sum if IAA is amongst the first markers to appear the log-hazard
is reduced by 0.71. This net effect can be derived as the sum of the direct effect in ηγ and the indirect effect
in ηα · ηµ with an average association of ηα = 1n
∑
i ηα(Ti) = 0.25. Additionally we do not observe a
direct effect of the age at seroconversion (βγ3 = −0.09; [-0.20, 0.01]).
In line with previous findings (Steck et al., 2011, 2015) these results indicate that the quantitative levels
of the marker IAA are informative for the rate of progression to T1D in the first years after seroconversion
with higher levels increasing the hazard of T1D. The direct relationship between the hazard and the baseline
covariate age at seroconversion is not supported by the model, suggesting that the previously established
influence of this covariate on T1D progression may be mediated by the marker levels, i.e. the effect in
the respective log-hazard is reduced if the marker levels over time are taken into account as in our flexible
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parameterization. We do not observe a time-varying association between IAA and the hazard of T1D
over time. There is much uncertainty around the nonlinear time-varying estimate of the association ηα(t),
potentially as a result of the flexibility in the estimation in combination with the amount of data in the
survival part.
6 Discussion and Outlook
We presented a flexible joint model that allows to fit a broad range of joint model specifications using
structured additive predictors for all model components. The approach is fully implemented in the R-
package bamlss. While the framework is very flexible, as illustrated by Table 1, the focus in this work
lies on the flexible modeling of individual trajectories and the specification of a time-varying association
between marker and event.
The proposed model shows satisfactory performance in various simulation settings and has the poten-
tial to offer new insights into complex relationships between biomarkers and time-to-event processes. Our
methods development was motivated by a specific research question from T1D studies and two correspond-
ing data sets. We saw that even by combining the two cohorts, the sample size of the data set considered
in the application in Section 5 is at the lower limit for the complexity of our model, as indicated by our
simulation study and by the width of the credibility intervals in the applied results. Nevertheless we found
a positive association between a disease-related biomarker and the occurrence of clinical T1D. Although
our model allows for a time-varying association between the biomarker and the event process at least in this
small data set it was estimated to be roughly constant. In consequence our flexible model can also be used
to check the modeling assumptions of simpler models that are commonly used. We aim to further explore
the relationship between T1D-specific autoantibodies and the progression to T1D in a larger data set from
a different, multinational T1D cohort (with sample size exceeding data setting b in our simulations) as in
Steck et al. (2015).
Due to the complexity of the model and its estimation, the computation speed is still a drawback in our
implementation. Hence we are constantly working on speeding up the computations further. As shown in
simulation 2, the posterior mode estimation offers a computationally efficient way to obtain point estimates
from a flexible joint model before starting the full MCMC sampling. These posterior mode estimates show
a precision similar to that of the posterior mean estimates. However, the credibility intervals obtained from
posterior modes are not wide enough, potentially due to the fact that the uncertainty around the variance
parameters τ2km is not included in the credibility intervals. In consequence, only the credibility intervals of
the posterior mean estimates should be used for inference.
As is well known in the survival context, the number of potential parameters in the model is limited by
the number of observed events (Harrell et al., 1996). This also holds in our approach for the predictors
in the survival part of the model, ηλ, ηγ , and ηα. We achieve to alleviate this issue to some extent by
the penalized approach, which decreases the effective number of degrees of freedom and thus allows for a
richer model than would be possible without a penalty. Still, we recommend to model only those effects as
non-linear functions, where a strong indication for non-linearity is given.
Within the framework of the presented additive joint model several further extensions are possible. As a
next step we aim to extend the model by including the derivative of the longitudinal trajectories to model the
event process similar to Ye et al. (2008), Brown (2009) and Rizopoulos et al. (2014), allowing to model the
potentially time-varying association between changes in the marker and the hazard. Further, functional his-
torical effects of the trajectories, including information on the history of the marker (Malfait and Ramsay,
2003; Gellar et al., 2014), could potentially offer additional insights into complex relationships between
markers and event processes.
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Appendix A
We derive score vectors and Hessians for the regression coefficients of every predictor. We introduce some
further notation to formulate these derivatives. For the time-varying predictors of the survival part k ∈
{λ, α, µ} the design matrix Xk(T) denotes the n× pk matrix of evaluations at the vector of survival times
T. For the time-varying predictors of the longitudinal part k ∈ {µ, σ} the N × pk design matrix Xk(t)
contains the evaluations at all observed subject-specific timepoints t. Let ` denote the log-likelihood, i.e.
the sum of the contributions of the longitudinal and survival submodels defined in (7) and (8). In more
detail, the full likelihood is
` [θ|T, δ,y] =δ> [Xλ(T)βλ + Xγβγ + Xα(T)βα ·Xµ(T)βµ]
−
n∑
i=1
exp
(
x>γiβγ
) ∫ Ti
0
exp
[
x>λi (u)βλ + x
>
αi (u)βα
(
x>µi (u)βµ
)]
du
− N
2
log(2pi)− 1>NXσ (t)βσ −
1
2
(y −Xµ (t)βµ)>R−1(y −Xµ (t)βµ)
Score Vectors
s(βµ) =
∂`
∂βµ
=Xµ (t)
>
R−1 (y −Xµ (t)βµ) + X>µ (T) diag(δ) [Xα (T)βα]
−
n∑
i=1
exp
(
x>γiβγ
) ∫ Ti
0
ωi(u) x
>
αi (u)βαxµi (u) du
s(βγ) =
∂`
∂βγ
=δ>Xγ −
n∑
i=1
exp
(
x>γiβγ
)
xγi
∫ Ti
0
ωi(u) du
s(βα) =
∂`
∂βα
=X>α (T) diag(δ) [Xµ (T)βµ]−
n∑
i=1
exp
(
x>γiβγ
) ∫ Ti
0
ωi(u) xαi (u)
(
x>µi (u)βµ
)
du
s(βλ) =
∂`
∂βλ
=δ>Xλ (T)−
n∑
i=1
exp
(
x>γiβγ
) ∫ Ti
0
ωi(u) xλi (u) du
s(βσ) =
∂`
∂βσ
=−Xσ (t)> 1N + [Xσ (t) (y −Xµ (t)βµ)]>R−1 (y −Xµ (t)βµ)
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Hessian
H(βµ) =
∂2`
∂βµ∂βµ>
=−Xµ (t)>R−1Xµ (t)
−
n∑
i=1
exp
(
x>γiβγ
) ∫ Ti
0
ωi(u)
[
x>αi (u)βα
]2
xµi (u)x
>
µi (u) du
H(βγ) =
∂2`
∂βγ∂β>γ
=−
n∑
i=1
exp
(
x>γiβγ
)
xγix
>
γi
∫ Ti
0
ωi(u) du
H(βα) =
∂2`
∂βα∂β>α
=−
n∑
i=1
exp
(
x>γiβγ
) ∫ Ti
0
ωi(u)
[
x>µi (u)βµ
]2
xαi (u)x
>
αi (u) du
H(βλ) =
∂2`i
∂βλ∂β>λ
=−
n∑
i=1
exp
(
x>γiβγ
) ∫ Ti
0
ωi(u) xλi (u)x
>
λi (u) du
H(βσ) =
∂2`
∂βσ∂β>σ
=− 2 [Xσ (t) (y −Xµ (t)βµ)]>R−1 [Xσ (t) (y −Xµ (t)βµ)]
where ωi(u) = exp
[
x>λi (u)βλ + x
>
αi (u)βα
(
x>µi (u)βµ
)]
andR = diag
(
exp [Xσ (t)βσ]
2
)
.
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Appendix B
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Figure A1 Results from the sensitivity analysis for the T1D data using 12 (i.e. 4 internal) knots for
both the overall mean and the functional random intercepts in the longitudinal submodel. (a) Observed
values (points) and estimated trajectories (lines) of the longitudinal marker values of log(IAA+1) for five
randomly selected subjects; (b) Estimated posterior mean of ηα(t) with 95% pointwise credibility bands
(shaded area), observed event times (rugs bottom) and censoring times (rugs top), and number of subjects
at risk per time point (bottom).
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Figure A2 Traceplots of the posterior samples for the intercept βα1 and the coefficient vector βα2 in
ηα(t).
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Figure A3 Traceplots of the posterior samples for the random intercepts βµ2(i) of subjects i = 1, . . . , 5,
and the coefficient vector βµ3(t, i) for subject i = 1 in ηµ(t).
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